肝硬化
内质网
RNA干扰
未折叠蛋白反应
炎症
癌症研究
自噬
转基因
纤维化
肝细胞癌
氧化应激
生物
转基因小鼠
细胞凋亡
医学
基因
病理
内科学
内分泌学
免疫学
细胞生物学
核糖核酸
遗传学
作者
Christine I. Wooddell,Keith Blomenkamp,Ryan M. Peterson,Vladimir M. Subbotin,Christian Schwabe,James Hamilton,Qili Chu,Dawn R. Christianson,Julia Hegge,John Kolbe,Holly Hamilton,Maria Afrazi,Bruce D. Given,David L. Lewis,Edward John Gane,Steven Brian Kanner,Jeffrey H. Teckman
出处
期刊:JCI insight
[American Society for Clinical Investigation]
日期:2020-06-18
卷期号:5 (12): e135348-
被引量:61
标识
DOI:10.1172/jci.insight.135348
摘要
The autosomal codominant genetic disorder alpha-1 antitrypsin (AAT) deficiency (AATD) causes pulmonary and liver disease. Individuals homozygous for the mutant Z allele accumulate polymers of Z-AAT protein in hepatocytes, where AAT is primarily produced. This accumulation causes endoplasmic reticulum (ER) stress, oxidative stress, damage to mitochondria, and inflammation, leading to fibrosis, cirrhosis, and hepatocellular carcinoma. The magnitude of AAT reduction and duration of response from first-generation intravenously administered RNA interference (RNAi) therapeutic ARC-AAT and then with next-generation subcutaneously administered ARO-AAT were assessed by measuring AAT protein in serum of the PiZ transgenic mouse model and human volunteers. The impact of Z-AAT reduction by RNAi on liver disease phenotypes was evaluated in PiZ mice by measuring polymeric Z-AAT in the liver; expression of genes associated with fibrosis, autophagy, apoptosis, and redox regulation; inflammation; Z-AAT globule parameters; and tumor formation. Ultrastructure of the ER, mitochondria, and autophagosomes in hepatocytes was evaluated by electron microscopy. In mice, sustained RNAi treatment reduced hepatic Z-AAT polymer, restored ER and mitochondrial health, normalized expression of disease-associated genes, reduced inflammation, and prevented tumor formation. RNAi therapy holds promise for the treatment of patients with AATD-associated liver disease. ARO-AAT is currently in phase II/III clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI